Literature DB >> 15525277

Down's syndrome astrocytes have greater antioxidant capacity than euploid astrocytes.

Jordi Sebastià1, Rosa Cristòfol, Maria Pertusa, David Vílchez, Núria Torán, Santiago Barambio, Eduard Rodríguez-Farré, Coral Sanfeliu.   

Abstract

Down's syndrome (trisomy 21) brain tissue is considered to be susceptible to oxidative injury, mainly because its increased Cu/Zn-superoxide dismutase (SOD1) activity is not followed by an adaptive rise in hydrogen peroxide metabolizing enzymes. In vitro, trisomic neurons suffer oxidative stress and degenerate. We studied the response of trisomy 21 neuron and astrocyte cultures to hydrogen peroxide injury and found that they were, respectively, more and less vulnerable than their euploid counterparts. Differences were detected 24 h after exposures in the region of 50 microm and 500 microm hydrogen peroxide for neuron and astrocyte cultures, respectively. Cytotoxicity results were paralleled by a decrease in cellular glutathione. In addition, trisomic astrocytes showed a lower basal content of superoxide ion and a higher clearance of hydrogen peroxide from the culture medium. In the presence of hydrogen peroxide, trisomic astrocytes maintained their concentration of intracellular superoxide and hydroperoxides at a lower level than euploid astrocytes. Consistent with these results, trisomic astrocytes in neuron coculture were more neuroprotective than euploid astrocytes against hydrogen peroxide injury. We suggest that SOD1 overexpression has beneficial effects on astrocytes, as it does in other systems with similarly high disposal of hydroperoxides. In addition to a higher enzymatic activity of SOD1, cultures of trisomic astrocytes showed slightly higher glutathione reductase activity than euploid cultures. Thus, trisomy 21 astrocytes showed a greater antioxidant capacity against hydrogen peroxide than euploid astrocytes, and they partially counteracted the oxidative vulnerability of trisomic neurons in culture.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15525277     DOI: 10.1111/j.1460-9568.2004.03686.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  9 in total

1.  Gender-Specific Neuroimmunoendocrine Response to Treadmill Exercise in 3xTg-AD Mice.

Authors:  Lydia Giménez-Llort; Yoelvis García; Karla Buccieri; Susana Revilla; Cristina Suñol; Rosa Cristofol; Coral Sanfeliu
Journal:  Int J Alzheimers Dis       Date:  2010-10-12

2.  Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome.

Authors:  Eduardo B Parisotto; Verónica Vidal; Susana García-Cerro; Sara Lantigua; Danilo Wilhelm Filho; Emilio J Sanchez-Barceló; Carmen Martínez-Cué; Noemí Rueda
Journal:  Neurochem Res       Date:  2016-07-23       Impact factor: 3.996

3.  Human iPSC-derived Down syndrome astrocytes display genome-wide perturbations in gene expression, an altered adhesion profile, and increased cellular dynamics.

Authors:  Blandine Ponroy Bally; W Todd Farmer; Emma V Jones; Selin Jessa; J Benjamin Kacerovsky; Alexandre Mayran; Huashan Peng; Julie L Lefebvre; Jacques Drouin; Arnold Hayer; Carl Ernst; Keith K Murai
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

4.  A role for thrombospondin-1 deficits in astrocyte-mediated spine and synaptic pathology in Down's syndrome.

Authors:  Octavio Garcia; Maria Torres; Pablo Helguera; Pinar Coskun; Jorge Busciglio
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

5.  γ-Tocotrienol does not substantially protect DS neurons from hydrogen peroxide-induced oxidative injury.

Authors:  Sue-Mian Then; Coral Sanfeliu; Gapor M Top; Wan Zurinah Wan Ngah; Musalmah Mazlan
Journal:  Nutr Metab (Lond)       Date:  2012-01-05       Impact factor: 4.169

Review 6.  Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease.

Authors:  Octavio García; Lisi Flores-Aguilar
Journal:  Front Cell Neurosci       Date:  2022-09-20       Impact factor: 6.147

7.  Redox processes in neurodegenerative disease involving reactive oxygen species.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

8.  Restoring microglial and astroglial homeostasis using DNA immunization in a Down Syndrome mouse model.

Authors:  Tomer Illouz; Ravit Madar; Arya Biragyn; Eitan Okun
Journal:  Brain Behav Immun       Date:  2018-10-25       Impact factor: 7.217

9.  Evidence of Energy Metabolism Alterations in Cultured Neonatal Astrocytes Derived from the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Bruna L Zampieri; Alberto C S Costa
Journal:  Brain Sci       Date:  2022-01-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.